HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuanying Zhu Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2022Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuanying Zhu Research Topics

Disease

4Neoplasms (Cancer)
01/2024 - 01/2018
1Poisoning
01/2024
1Immune System Diseases (Immune Disorders)
01/2024
1Diabetic Retinopathy (Retinopathy, Diabetic)
10/2023
1Eye Diseases (Eye Disease)
10/2023
1Glaucoma
10/2023
1Inflammation (Inflammations)
10/2023
1Ischemia
10/2023
1Retinal Artery Occlusion
10/2023
1Reperfusion Injury
10/2023
1Drug-Related Side Effects and Adverse Reactions
01/2023
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018

Drug/Important Bio-Agent (IBA)

1ColchicineFDA LinkGeneric
01/2024
1Amino AcidsFDA Link
01/2024
1rheinIBA
10/2023
1Glucose (Dextrose)FDA LinkGeneric
10/2023
1Oxygen (Dioxygen)IBA
10/2023
1Peptides (Polypeptides)IBA
10/2023
1Retinaldehyde (Retinal)IBA
10/2023
1danggui buxue decoctionIBA
01/2023
1Fibroins (Fibroin)IBA
01/2022
1gamma-sitosterol (beta-sitosterol)IBA
01/2022
1aloe emodinIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Drug CarriersIBA
01/2022
1Keratin-19 (Keratin 19)IBA
01/2018
1Carcinoembryonic AntigenIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1AntigensIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2023
1Therapeutics
01/2022